ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/N-((2R,21R,24S)-1-amino-24-(2-(2-(2-aminoacetamido)acetamido)acetamido)-2,21-bis(mercaptomethyl)-1,4,20,23-tetraoxo-7,10,13,16-tetraoxa-3,19,22-triazaoctacosan-28-yl)-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxahentetracontan-41-amide
C57H109N9O25S2
1384.7 g/mol
Research Reagent

N-((2R,21R,24S)-1-amino-24-(2-(2-(2-aminoacetamido)acetamido)acetamido)-2,21-bis(mercaptomethyl)-1,4,20,23-tetraoxo-7,10,13,16-tetraoxa-3,19,22-triazaoctacosan-28-yl)-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxahentetracontan-41-amide

CAS2959475-51-3
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a research reagent designed for conjugation studies, featuring a polyethylene glycol-based structure with multiple amide and ether linkages. Its large, flexible molecular architecture makes computational conformer generation impractical, highlighting its specialized nature for advanced bioconjugation applications.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

9-(3-bromophenyl-2,4,5,6-d4)-9H-carbazole-1,2,3,4,5,6,7,8-d8

CAS2961037-70-5

research compound

ReferenceSame Category

L-selenocystine

CAS29621-88-3

research compound

ReferenceSame Category

2-Fluoro-4-iodoaniline

CAS29632-74-4

research compound

ReferenceSame Category

3,5-Dihydroxybenzyl alcohol

CAS29654-55-5

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-N-[(2R)-1-[2-[2-[2-[2-[3-[[(2R)-1-amino-1-oxo-3-sulfanylpropan-2-yl]amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethylamino]-1-oxo-3-sulfanylpropan-2-yl]-6-[3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]hexanamide

InChIKey

HZIKEVLAEMPTBK-HYGNTPKVSA-N

SMILES

COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CS)C(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](CS)C(=O)N)NC(=O)CNC(=O)CNC(=O)CN

Synonyms (1)

—

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→